Crizanlizumab in sickle cell disease

Kenneth I. Ataga, Abdullah Kutlar, Julie Kanter

Research output: Contribution to journalLetter

5 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1795-1796
Number of pages2
JournalNew England Journal of Medicine
Volume376
Issue number18
DOIs
StatePublished - May 4 2017

Fingerprint

Sickle Cell Anemia

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Crizanlizumab in sickle cell disease. / Ataga, Kenneth I.; Kutlar, Abdullah; Kanter, Julie.

In: New England Journal of Medicine, Vol. 376, No. 18, 04.05.2017, p. 1795-1796.

Research output: Contribution to journalLetter

Ataga, Kenneth I. ; Kutlar, Abdullah ; Kanter, Julie. / Crizanlizumab in sickle cell disease. In: New England Journal of Medicine. 2017 ; Vol. 376, No. 18. pp. 1795-1796.
@article{b16da949eb6f4489810809d66b7c02fa,
title = "Crizanlizumab in sickle cell disease",
author = "Ataga, {Kenneth I.} and Abdullah Kutlar and Julie Kanter",
year = "2017",
month = "5",
day = "4",
doi = "10.1056/NEJMc1703162",
language = "English (US)",
volume = "376",
pages = "1795--1796",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "18",

}

TY - JOUR

T1 - Crizanlizumab in sickle cell disease

AU - Ataga, Kenneth I.

AU - Kutlar, Abdullah

AU - Kanter, Julie

PY - 2017/5/4

Y1 - 2017/5/4

UR - http://www.scopus.com/inward/record.url?scp=85044534502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044534502&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1703162

DO - 10.1056/NEJMc1703162

M3 - Letter

C2 - 28467874

AN - SCOPUS:85044534502

VL - 376

SP - 1795

EP - 1796

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 18

ER -